An integrative model of cellular states, plasticity, and genetics for glioblastoma C Neftel, J Laffy, MG Filbin, T Hara, ME Shore, GJ Rahme, AR Richman, ... Cell 178 (4), 835-849. e21, 2019 | 2040 | 2019 |
Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy X Lan, DJ Jörg, FMG Cavalli, LM Richards, LV Nguyen, RJ Vanner, ... Nature 549 (7671), 227-232, 2017 | 466 | 2017 |
Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity M Meyer, J Reimand, X Lan, R Head, X Zhu, M Kushida, J Bayani, ... Proceedings of the National Academy of Sciences 112 (3), 851-856, 2015 | 439 | 2015 |
ASCL1 reorganizes chromatin to direct neuronal fate and suppress tumorigenicity of glioblastoma stem cells NI Park, P Guilhamon, K Desai, RF McAdam, E Langille, M O’Connor, ... Cell stem cell 21 (2), 209-224. e7, 2017 | 236 | 2017 |
Inhibition of dopamine receptor D4 impedes autophagic flux, proliferation, and survival of glioblastoma stem cells S Dolma, HJ Selvadurai, X Lan, L Lee, M Kushida, V Voisin, H Whetstone, ... Cancer cell 29 (6), 859-873, 2016 | 210 | 2016 |
PRMT5 inhibition disrupts splicing and stemness in glioblastoma P Sachamitr, JC Ho, FE Ciamponi, W Ba-Alawi, FJ Coutinho, ... Nature communications 12 (1), 979, 2021 | 116 | 2021 |
MLL5 orchestrates a cancer self-renewal state by repressing the histone variant H3. 3 and globally reorganizing chromatin M Gallo, FJ Coutinho, RJ Vanner, T Gayden, SC Mack, A Murison, ... Cancer cell 28 (6), 715-729, 2015 | 112 | 2015 |
Medulloblastoma arises from the persistence of a rare and transient Sox2+ granule neuron precursor HJ Selvadurai, E Luis, K Desai, X Lan, MC Vladoiu, O Whitley, C Galvin, ... Cell reports 31 (2), 2020 | 55 | 2020 |
Challenges in diagnosis and treatment of pancreatic exocrine insufficiency among patients with pancreatic ductal adenocarcinoma X Lan, G Robin, J Kasnik, G Wong, O Abdel-Rahman Cancers 15 (4), 1331, 2023 | 14 | 2023 |
Burnout and fatigue amongst internal medicine residents: A cross-sectional study on the impact of alternative scheduling models on resident wellness JH Yuan, Y Huang, BK Rosgen, S Donnelly, X Lan, SJ Katz Plos one 18 (9), e0291457, 2023 | 12 | 2023 |
Exploring the relationship between obesity, metabolic syndrome and neuroendocrine neoplasms X Lan, N Fazio, O Abdel-Rahman Metabolites 12 (11), 1150, 2022 | 8 | 2022 |
Single cell derived clonal analysis of human glioblastoma links functional and genomic heterogeneity PB Dirks, M Meyer, J Reimand, X Lan, R Head, X Zhu, M Kushida, ... Neuro-oncology 16 (Suppl 3), iii14, 2014 | 5 | 2014 |
Chromatin blueprint of glioblastoma stem cells reveals common drug candidates for distinct subtypes P Guilhamon, MM Kushida, G MacLeod, SAM Tonekaboni, FMG Cavalli, ... bioRxiv, 370726, 2018 | 3 | 2018 |
Systemic Lupus Erythematosus: Initial Manifestation as Cardiac Tamponade? Z Ma, X Lan, KR Bainey Annals of Internal Medicine: Clinical Cases 2 (8), e221351, 2023 | 1 | 2023 |
Clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma X Lan, O Abdel-Rahman Translational Cancer Research 12 (8), 2232, 2023 | | 2023 |
Isolation and functional characterization of human glioblastoma stem cells X Lan, PB Dirks, L Lee, MM Kushida, C Che, N Rastegar | | 2017 |
Breaking Advances S Dolma, HJ Selvadurai, X Lan, L Lee, M Kushida, V Voisin Nat Genet 48, 725-32, 2016 | | 2016 |
Abstract B29: Defining subclonal signaling heterogeneity in glioblastoma multiforme (GBM) X Lan, M Meyer, J Reimand, X Zhu, M Kushida, R Head, I Clarke, G Bader, ... Cancer Research 73 (19_Supplement), B29-B29, 2013 | | 2013 |